UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical infectious diseases, ISSN 1058-4838, 05/2018, Volume 66, Issue 9, pp. 1352 - 1359
Treatment uptake | HIV/HCV coinfection | Direct-acting antivirals | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiretroviral drugs | Sexually transmitted diseases--STD | Sex | Viruses | Infections | Ribonucleic acid--RNA | Patients | Hepatitis | α-Interferon | Disease transmission | Human immunodeficiency virus--HIV | Men | Interferon | Hepatitis C virus | Hepatitis C | Index Medicus
Journal Article
AIDS (London), ISSN 0269-9370, 04/2019, Volume 33, Issue 5, pp. 833 - 844
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Liver Cirrhosis - etiology | Markov Chains | Humans | Netherlands - epidemiology | Male | Coinfection - virology | Disease Progression | Liver Cirrhosis - virology | Homosexuality, Male | Liver Cirrhosis - pathology | Adult | Hepatitis C - complications | Retrospective Studies | HIV Infections - physiopathology | Hepatitis C - pathology | Complications and side effects | Development and progression | Hepatitis C | Liver cirrhosis | MSM (Men who have sex with men) | Health aspects | Risk factors | Index Medicus | AIDS/HIV
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 2019, Volume 81, Issue 5, pp. 562 - 571
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Blood Pressure | Cardiovascular Diseases - etiology | Anti-Retroviral Agents - therapeutic use | Risk Assessment | Cholesterol - blood | Humans | Middle Aged | Risk Factors | Male | CD4 Lymphocyte Count | Propensity Score | Netherlands | Algorithms | HIV Infections - complications | Cardiovascular Diseases - epidemiology | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Statistical analysis | Risk groups | Health risks | Performance prediction | Cardiovascular disease | Calibration | Statistical tests | Cholesterol | Antiretroviral therapy | Goodness of fit | CD4 antigen | Discrimination | Antiretroviral agents | Human immunodeficiency virus--HIV | Risk assessment | Data collection | Blood pressure | Cardiology | Cardiovascular diseases | Health risk assessment | Heart diseases | Smoking | Index Medicus | AIDS/HIV
Journal Article
HIV medicine, ISSN 1464-2662, 2018, Volume 19, Issue 3, pp. 216 - 226
co‐medication | direct‐acting antivirals | HIV | combination antiretroviral therapy | hepatitis C | drug–drug interactions | co-medication | direct-acting antivirals | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Hepacivirus - drug effects | Antiviral Agents - pharmacology | Prospective Studies | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Coinfection - drug therapy | Humans | Middle Aged | Male | Practice Patterns, Physicians | Netherlands | Drug Interactions | Observational Studies as Topic | Female | HIV Infections - drug therapy | Retrospective Studies | Sustained Virologic Response | Hepatitis | Complications and side effects | Highly active antiretroviral therapy | Squamous cell carcinoma | Protease inhibitors | Comorbidity | Proteases | Drug interactions | Digital integrated circuits | Hepatitis C virus | Medical personnel | Drugs | Therapy | Physicians | Chronic infection | Viruses | Patients | Antiretroviral therapy | Antiretroviral agents | Human immunodeficiency virus--HIV | Hepatitis C | Index Medicus
Journal Article
Canadian geriatrics journal CGJ, 09/2017, Volume 20, Issue 3, p. 120
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 02/2018, Volume 66, Issue 4, pp. 594 - 603
VIRAL LOAD | second-line | SCALE-UP | antiretroviral therapy | HIV-1 DRUG-RESISTANCE | ADULTS | RANDOMIZED-TRIAL | INFECTED CHILDREN | OPEN-LABEL | switch | HIV | children | VIROLOGICAL FAILURE | ADOLESCENTS | INFANTS | Second-line | Children | Switch | Antiretroviral therapy | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiretroviral drugs | Therapy | RNA-directed DNA polymerase | Nevirapine | Medical treatment | Switches | Durability | Viruses | Proteinase inhibitors | Efavirenz | Children & youth | Incidence | Confidence intervals | Immunosuppression | Non-nucleoside reverse transcriptase inhibitors | Protease inhibitors | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Risk assessment | Failure analysis | Age | Index Medicus | Life Sciences | Medicin och hälsovetenskap
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 11/2015, Volume 212, Issue 9, pp. 1407 - 1419
VIRUSES | no | cohort study | hepatitis C | sex | re-infection | IFNL4 | injecting drug use | viral resolution | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Hepacivirus - drug effects | Hepacivirus - isolation & purification | Recurrence | Acute Disease | Follow-Up Studies | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Proportional Hazards Models | Genotype | Male | Treatment Outcome | Viral Load | Young Adult | Interleukins - genetics | Hepatitis C - virology | Sex Factors | Adult | Female | Polymorphism, Single Nucleotide | RNA, Viral - isolation & purification | Cohort Studies | Care and treatment | Cohort analysis | Usage | Research | Hepatitis C | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
AIDS (London), ISSN 0269-9370, 10/2019, Volume 33, Issue 12, pp. 1897 - 1910
VIRAL LOAD | VELOCITY | HIV | Europe | perinatal | MASS | growth | puberty | Thailand | height | CHILDREN | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Index Medicus | AIDS/HIV | Life Sciences | Human health and pathology | Infectious diseases | Epidemiology and Social | Medicin och hälsovetenskap
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 02/2020, Volume 70, Issue 3, pp. 404 - 415
Journal Article